[HTML][HTML] Coronavirus-induced coagulopathy during the course of disease

MS Friedrich, JD Studt, J Braun, DR Spahn… - PLoS One, 2020 - journals.plos.org
Background A significant proportion of patients with coronavirus disease 19 (COVID-19)
suffer from excessive coagulation activation and coagulopathy which is associated with an …

[HTML][HTML] Risk management and treatment of coagulation disorders related to COVID-19 infection

C Zanza, F Racca, Y Longhitano, A Piccioni… - International Journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease. Bilateral
pneumonia, acute respiratory failure, systemic inflammation, endothelial dysfunction and …

COVID-19 and its implications for thrombosis and anticoagulation

SA Berkman, VF Tapson - Seminars in respiratory and critical …, 2021 - thieme-connect.com
Venous thromboembolism, occlusion of dialysis catheters, circuit thrombosis in
extracorporeal membrane oxygenation (ECMO) devices, acute limb ischemia, and isolated …

[HTML][HTML] Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19

T Wang, R Chen, C Liu, W Liang, W Guan… - The Lancet …, 2020 - thelancet.com
Comment www. thelancet. com/haematology Vol 7 May 2020 e363 risk factors (aged 40
years or older, had hepatic failure (international normalised ratio> 1∙ 5), had severe renal …

Thromboinflammation and the hypercoagulability of COVID‐19

JM Connors, JH Levy - Journal of thrombosis and haemostasis, 2020 - jthjournal.org
The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …

COVID‐19–related laboratory coagulation findings

KMJ Devreese - International journal of laboratory hematology, 2021 - Wiley Online Library
The alterations in the hemostatic balance in COVID‐19 patients are strongly disturbed and
contribute to a high prothrombotic status. The high rate of venous thromboembolism in …

Venous thromboembolism in the era of COVID-19

KG Kyriakoulis, DG Kokkinidis, IA Kyprianou… - …, 2021 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) does not only affect the respiratory system but
appears to be a systemic disease. Venous thromboembolism is a common manifestation in …

[HTML][HTML] Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan

S Oba, T Hosoya, M Amamiya, T Mitsumura… - Frontiers in …, 2021 - frontiersin.org
[Background] Thrombosis is a characteristic complication in Coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

[HTML][HTML] Covid-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome

M Ranucci, C Sitzia, E Baryshnikova… - Journal of clinical …, 2020 - mdpi.com
Background: Coronavirus Disease 2019 (COVID-19)-associated coagulopathy is
characterized by a prothrombotic state not yet comprehensively studied. We investigated the …

[HTML][HTML] Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting-a report of 4 cases

S Overstad, E Tjonnfjord, L Garabet, S Fronas… - Thrombosis …, 2020 - ncbi.nlm.nih.gov
The clinical manifestations of coronavirus disease 2019 (COVID-19) vary widely from
asymptomatic to life-threatening illness. According to early data from China, an estimated …